Blood test plus genetic score may sharpen recurrence prediction in endometrial cancer
Knowledge-focused
Ongoing
This observational study looks at whether combining a blood test that detects tumor DNA (ctDNA) with a new genetic risk score can better predict if endometrial cancer will come back after surgery. Researchers will follow 52 women who had a hysterectomy for endometrial cancer, col…
Sponsor: Guizhou Provincial People's Hospital • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC